Taku Ito-Kureha

6PUBLICATIONS
37CO-AUTHORS
Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 17, 2026
A distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle-based mRNA vaccines.

|Apr 01, 2025
Tob negatively regulates NF-κB activation in breast cancer through its association with the TNF receptor complex.

Miho Tokumasu, Atsuko Sato, Taku Ito-Kureha

|Aug 05, 2024
Correction to "The thymocyte-specific RNA-binding protein Arpp21 provides TCR repertoire diversity by binding to the 3'-UTR and promoting Rag1 mRNA expression".

Meng Xu, Taku Ito-Kureha, Hyun-Seo Kang

|Mar 12, 2024
The thymocyte-specific RNA-binding protein Arpp21 provides TCR repertoire diversity by binding to the 3'-UTR and promoting Rag1 mRNA expression.

Meng Xu, Taku Ito-Kureha, Hyun-Seo Kang

|Jun 29, 2023
The mRNA methyltransferase Mettl3 modulates cytokine mRNA stability and limits functional responses in mast cells.

Cristina Leoni, Marian Bataclan, Taku Ito-Kureha

|Jul 25, 2022
The function of Wtap in N6-adenosine methylation of mRNAs controls T cell receptor signaling and survival of T cells.

Taku Ito-Kureha, Cristina Leoni, Kayla Borland

Pageof 1

Frequent Collaborators

4 joint publications

Vigo Heissmeyer

3 joint publications

Julian König

2 joint publications

Regina Feederle

2 joint publications

Carolin Daniel